{"Symbol": "SOLV", "AssetType": "Common Stock", "Name": "Solventum Corp.", "Description": "Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.", "CIK": "1964738", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS", "Address": "3M CENTER, BUILDING 275-6W, 2510 CONWAY AVENUE EAST, MAPLEWOOD, MN, UNITED STATES", "OfficialSite": "https://www.solventum.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "11234816000", "EBITDA": "1647000000", "PERatio": "23.53", "PEGRatio": "None", "BookValue": "17.12", "DividendPerShare": "None", "DividendYield": "None", "EPS": "2.76", "RevenuePerShareTTM": "47.66", "ProfitMargin": "0.058", "OperatingMarginTTM": "0.0954", "ReturnOnAssetsTTM": "0.0481", "ReturnOnEquityTTM": "0.0655", "RevenueTTM": "8254000000", "GrossProfitTTM": "4612000000", "DilutedEPSTTM": "2.76", "QuarterlyEarningsGrowthYOY": "-0.886", "QuarterlyRevenueGrowthYOY": "0.019", "AnalystTargetPrice": "80.89", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "1", "AnalystRatingHold": "9", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "23.53", "ForwardPE": "11.7", "PriceToSalesRatioTTM": "1.361", "PriceToBookRatio": "3.797", "EVToRevenue": "2.239", "EVToEBITDA": "12.1", "Beta": "None", "52WeekHigh": "85.92", "52WeekLow": "47.16", "50DayMovingAverage": "73.51", "200DayMovingAverage": "68.28", "SharesOutstanding": "173003000", "DividendDate": "None", "ExDividendDate": "None"}